oral semaglutide novo nordisk wins EU approval for Wegovy weight-loss pill Ozempic and Wegovy pills now
Description
GLP-1 support helps curb cravings, regulates appetite, and boosts metabolic health
- 71 pounds (from an average starting weight of 248)
The success of these agents in preclinical models and clinical trials suggests a promising future for multiagonists in the treatment of metabolic diseases, with the most recent glucose-dependent insulinotropic peptide receptor:glucagon-like peptide 1 receptor:glucagon receptor (GIPR:GLP-1R:GCGR) triagonists rivaling the efficacy of bariatric surgery
There's a fundamental shift underway in the pharmaceutical industry
